Zachary W Reichenbach Selected Research

1- (4- (1,1- dimethylheptyl)- 2,6- dimethoxyphenyl)- 3- methylcyclohexanol

1/2022

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zachary W Reichenbach Research Topics

Disease

2	Chronic Pain 01/2022 - 04/2015
1	Inflammation (Inflammations) 01/2022
1	Hyperalgesia 01/2022
1	Infarction (Infarctions) 02/2018
1	Stroke (Strokes) 02/2018
1	Ischemia 02/2018
1	Pain (Aches) 04/2015
1	Acute Pain 04/2015
1	Thrombosis (Thrombus) 07/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2012

Drug/Important Bio-Agent (IBA)

3	CannabinoidsIBA 01/2022 - 04/2015
2	CB2 Cannabinoid ReceptorIBA 01/2022 - 02/2018
2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 04/2015
1	1- (4- (1,1- dimethylheptyl)- 2,6- dimethoxyphenyl)- 3- methylcyclohexanolIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018
1	Opioid Analgesics (Opioids)IBA 04/2015
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 07/2012
1	Peptide Hydrolases (Proteases)FDA Link 07/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2012
1	Factor XIa (Coagulation Factor XIa)IBA 07/2012

Therapy/Procedure

2	Therapeutics 04/2015 - 07/2012
1	Intravenous Administration 07/2012